WallStreetZenWallStreetZen

NASDAQ: IXHL
Incannex Healthcare Inc Stock Forecast, Predictions & Price Target

Be the first to know when Wall Street analysts revise their IXHL stock forecasts and price targets.

Forecast return on equity

Is IXHL forecast to generate an efficient return?

Forecast return on assets

Is IXHL forecast to generate an efficient return on assets?

IXHL revenue forecast

What is IXHL's revenue in the next 1 years based on estimates from 1 analyst?
Avg 1 year Forecast
$50.0k

IXHL vs Pharmaceutical Stocks

TickerPricePrice TargetUp/downsideConsensus
IXHL$3.59N/AN/A
SCYX$1.47N/AN/A
RGC$4.50N/AN/A
RMTI$1.66$7.00+321.69%Strong Buy
EGRX$5.24N/AN/A

Incannex Healthcare Stock Forecast FAQ

What is IXHL's revenue growth forecast for 2024-2024?

(NASDAQ: IXHL) Incannex Healthcare's forecast annual revenue growth rate of N/A is not forecast to beat the US Drug Manufacturers - Specialty & Generic industry's average forecast revenue growth rate of N/A, and while it is not forecast to beat the US market's average forecast revenue growth rate of N/A.

Incannex Healthcare's revenue in 2024 is $0.

In 2024, IXHL is forecast to generate $793,656 in revenue, with the lowest revenue forecast at $793,656 and the highest revenue forecast at $793,656.

If you're new to stock investing, here's how to buy Incannex Healthcare stock.

What is IXHL's forecast return on assets (ROA) for 2024-2024?

(NASDAQ: IXHL) forecast ROA is N/A, which is lower than the forecast US Drug Manufacturers - Specialty & Generic industry average of 9.86%.

What is IXHL's forecast return on equity (ROE) for 2024-2024?

(NASDAQ: IXHL) forecast ROE is N/A, which is considered weak.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.